Picture of Longeveron logo

LGVN Longeveron Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for Longeveron, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-3.72-17-18.8-21.4-16
Depreciation
Non-Cash Items0.0837.583.732.542.39
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.489-1.090.238-1.08-1.24
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities-2.36-9.64-14-19-13.9
Capital Expenditures-0.262-1.31-0.856-0.694-0.992
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-9.390.1798.880.352
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-0.262-10.7-0.6778.19-0.64
Financing Cash Flow Items-0.01318-0.5115.16-0.366
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1.5845.2-0.5095.2628.8
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1.0524.8-15.2-5.5514.3